Posts

Showing posts from May, 2026

Hantavirus, Zinc and Dr Zelenko: Could a Simple Antiviral Strategy Work Against RNA Viruses?

Image
In May 2026, a resurfaced video from the late Vladimir Zelenko (“Dr. Zev” Zelenko) went viral again on X, generating more than 1.5 million views and reigniting debate about zinc, vitamin D, and low-cost antiviral strategies. In the 2-minute clip (video below), Zelenko explains a concept he promoted heavily during the COVID-19 pandemic: many dangerous viruses share the same replication machinery, and therefore may share similar therapeutic vulnerabilities. The video specifically references: COVID-19 Influenza RSV Ebola virus disease Marburg virus disease Hantavirus infections His argument centers on zinc, zinc ionophores, and RNA-dependent RNA polymerase (RdRp), the enzyme many RNA viruses use to replicate. But does the science support the claim? Here’s a balanced, evidence-based review. What Is Hantavirus? Hantaviruses are rodent-borne RNA viruses that can cause severe human disease. Depending on the region and viral strain, infection may lead to: Hantavirus Pulmonary Syndrome (HPS) H...

Cruise Ship Virus Outbreaks in 2026: Hantavirus and Norovirus Raise Global Health Concerns

Image
Two separate viral outbreaks aboard cruise ships in May 2026 have drawn international attention: a rare and deadly hantavirus cluster linked to the expedition ship MV Hondius , and a large norovirus outbreak aboard the Caribbean Princess . While the diseases are very different, both incidents highlight how cruise ships can amplify infectious disease transmission in confined environments. Rare Hantavirus Outbreak Linked to MV Hondius Cruise Ship A multinational outbreak of Andes hantavirus infection aboard the Dutch-flagged expedition cruise ship MV Hondius has resulted in at least eight confirmed or suspected cases and three deaths as of May 2026. ( World Health Organization ) The outbreak began after the ship departed Ushuaia, Argentina, in April 2026. Initial symptoms among passengers included fever, respiratory distress, fatigue, and rapidly progressive lung complications. The cruise later became stranded off Cape Verde before eventually docking in Tenerife in Spain’s Canary Island...

Hantavirus Outbreak 2026: Symptoms, Deaths, Human Transmission and What You Need to Know

Image
On 2 May 2026, a cluster of passengers with severe respiratory illness aboard a cruise ship was reported to the World Health Organization (WHO). The vessel was carrying 147 passengers and crew members. As of 4 May 2026, seven cases — including two laboratory-confirmed hantavirus infections and five suspected cases — had been identified. Among these cases were three deaths, one critically ill patient, and three individuals with mild symptoms. Illness onset occurred between 6 and 28 April 2026 and was characterized by fever, gastrointestinal symptoms, rapid progression to pneumonia, acute respiratory distress syndrome (ARDS), and shock. Further investigations remain ongoing. The outbreak response includes coordinated international public health measures such as in-depth epidemiological investigations, case isolation and medical care, patient evacuation, and laboratory testing. Human hantavirus infection is primarily acquired through contact with the urine, feces, or saliva of infected ro...

McCairn–Edogawa Protocol: Viral Long COVID Cure from Japan?

Image
The McCairn Protocol (Edogawa–McCairn Protocol): Overview and Mechanistic Rationale The McCairn Protocol (also referred to as the Edogawa–McCairn Protocol ) is an experimental, two-phase treatment approach promoted by Kevin McCairn in collaboration with Edogawa Hospital. It is primarily proposed for individuals with Long COVID and post-mRNA vaccine–associated syndromes , targeting hypothesized drivers such as persistent spike protein, amyloid-like fibrin microclots, autoantibodies, chronic inflammation, and associated vascular or neurological dysfunction. Phase 1: Double Filtration Plasmapheresis (DFPP) / Plasma Adsorption (“Cleansing”) Double Filtration Plasmapheresis (DFPP) is a specialized form of therapeutic apheresis currently used in parts of Asia, including Japan, for selected autoimmune, neurological, and metabolic conditions. Procedure Blood is withdrawn, often via a large-bore catheter (e.g., internal jugular access). It is passed through a dual-filtration syste...

Dr Peter McCullough: How to Measure Your Spike Protein Antibody (2026)

Image
Dr. McCullough explained (1) that the spike protein is an engineered, synthetic molecule roughly 1,200 amino acids long and resistant to degradation by the body’s normal proteases. He described how the protein was modified in laboratory settings (notably at the Wuhan Institute of Virology) to tightly bind to the ACE2 receptor, which is found throughout the body—in the lungs, heart, endothelium, kidneys, and brain. Because this receptor regulates angiotensin metabolism, older individuals with fewer ACE2 sites catabolize the spike less efficiently, leading to worse outcomes. Whether introduced by infection or by genetic‑code‑based vaccines, McCullough asserted, the persistent spike damages tissues directly and through chronic inflammation, micro‑clotting, and autoimmune cross‑reactivity. He cited more than 300 papers documenting spike deposits in the heart, brain, and vascular tissue, relating these findings to post‑vaccine myocarditis, strokes, and clotting disorders. A chief diagnostic...

Labels

Show more